Physician profile
Amit K Gupta
NPI 1265640148
$1,636.93
in general payments reported to CMS, 2019-2025
17 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $469 · 2021: $224 · 2022: $215 · 2023: $60.29 · 2024: $21.73 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $309.96 | 2021-2022 | |
| Medicure Pharma INC. | $300.00 | 2020 | |
| Biotronik INC. | $144.69 | 2020-2022 | |
| Heartflow, INC. | $138.49 | 2025 | |
| Abiomed | $132.17 | 2019 | |
| Pfizer INC. | $123.00 | 2019 | |
| Ekos Corporation | $98.23 | 2019 | |
| Abbott Laboratories | $97.46 | 2020-2025 | Triclip |
| Cook Medical LLC | $93.91 | 2020 | |
| Philips North America LLC | $60.29 | 2023 | |
| Amgen INC. | $36.53 | 2019-2020 | |
| Boston Scientific Corporation | $31.20 | 2022 | |
| Biotronik Nro, INC. | $21.73 | 2024 | Prospera |
| Arbor Pharmaceuticals, INC. | $20.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11.10 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.